BioMed Realty Trust, Inc. (BMR) Tops Q1 EPS by 3c

After the close, BioMed Realty Trust, Inc. (NYSE: BMR) reported Q1 AFFO of $0.38, $0.03 better than the analyst estimate of $0.35. Revenue for the quarter came in at $166.87 million, versus $160.45 million reported last year.

Commenting on the first quarter results, BioMed Realty's Chairman and Chief Executive Officer, Alan D. Gold, said, "We remain focused on providing real estate solutions that serve as the connection point for the academic, medical research and commercial biotech communities. Our recent accomplishments clearly demonstrate our continued strong execution on this strategy as illustrated by the significant leasing in Philadelphia and San Diego and our recently announced acquisition in New Haven, on the front doorsteps of Yale University. We recognize and are leveraging the critical nature of proximity and the growing desire of commercial pharmaceutical companies and life science research organizations to be located together in collaborative communities adjacent to the important centers of academic research, including Yale University, University of Pennsylvania, Harvard University and University of California, San Diego."

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c
• Standard BioTools (LAB) Announces Operational Restructuring Plan, Cuts 10% Staff